A Study of the Use of Text Message Reminders to Take Palbociclib

  • STATUS
    Recruiting
  • participants needed
    200
  • sponsor
    Memorial Sloan Kettering Cancer Center
Send
Updated on 16 February 2024
See if I qualify
treatment regimen
breast carcinoma
palbociclib
cancer diagnosis
fulvestrant
faslodex

Summary

The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.

Details
Condition Breast Cancer, Breast Cancer
Age 18years - 100years
Treatment Paper Drug Diary, OhMD APP
Clinical Study IdentifierNCT04216576
SponsorMemorial Sloan Kettering Cancer Center
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance)
>/= 18 years of age
Able to speak, read and write English
Willingness and ability to send and receive text messages with intervention app
Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application
Criteria applicable for both Control and Intervention groups
Flip-phones do not support OhMD Application and thus ineligible to participate
Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)

Exclusion Criteria

History of taking palbociclib (Ibrance)
Patients whose caregivers coordinate their health care
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

treatment regimen
breast carcinoma
palbociclib
cancer diagnosis
fulvestrant
faslodex

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.